发明名称 COMPOSITION FOR DIABETIC COMPLICATION, AND TREATMENT THEREOF
摘要 PROBLEM TO BE SOLVED: To obtain the subject composition useful for treatment of a diabetic complication by including an aldose reductase inhibitor, selective cyclooxygenase-2 (COX-2) inhibitor, and pharmaceutically allowable carrier, base or diluent. SOLUTION: This composition contains (A) an aldose reductase inhibitor, prodrug thereof or pharmaceutically allowable salt thereof, (B) a COX-2 inhibitor shown by formula I (R1 is a sulfamyl; R2 is a haloalkyl; R3 is a hydride or the like; and R4 is an aryl or the like), or formula II (R5 is an alkyl or the like; R6 is a cycloalkyl or the like; and R7 is a lower alkyl or the like), prodrug thereof or pharmaceutically allowable salt thereof, and (C) a pharmaceutically allowable carrier, base or diluent. It is preferable that the component A is fidarestat or zopolrestat, and component celecoxib or valdecoxib.
申请公布号 JP2001039872(A) 申请公布日期 2001.02.13
申请号 JP20000199068 申请日期 2000.06.30
申请人 PFIZER PROD INC 发明人 MYLARI BANAVARA LAKSHMAN
分类号 C07D231/12;A61K31/19;A61K31/33;A61K31/395;A61K31/41;A61K31/415;A61K31/4155;A61K31/4188;A61K31/42;A61K31/425;A61K31/44;A61K31/47;A61K31/4738;A61K31/495;A61K31/496;A61K31/502;A61K31/517;A61K45/00;A61K45/06;A61P3/00;A61P3/10;A61P9/10;A61P13/12;A61P27/02;A61P27/12;C07D261/08;(IPC1-7):A61K31/415;A61K31/418;A61K31/473 主分类号 C07D231/12
代理机构 代理人
主权项
地址